[1]CurrentPatentAssignee:NURIXTHERAPEUTICSINC;GILEADSCIENCESINC-WO2021/168197,2021,A1Locationinpatent:Page/Pagecolumn110-111
[2]CurrentPatentAssignee:GILEADSCIENCESINC;NURIXTHERAPEUTICSINC-WO2021/226262,2021,A1Locationinpatent:Page/Pagecolumn72;99
[3]CurrentPatentAssignee:GILEADSCIENCESINC;NURIXTHERAPEUTICSINC-WO2021/226262,2021,A1Locationinpatent:Page/Pagecolumn72;99
[1]CurrentPatentAssignee:NURIXTHERAPEUTICSINC;GILEADSCIENCESINC-WO2021/168197,2021,A1Locationinpatent:Page/Pagecolumn112
[2]CurrentPatentAssignee:GILEADSCIENCESINC;NURIXTHERAPEUTICSINC-WO2021/226262,2021,A1Locationinpatent:Page/Pagecolumn74
[3]CurrentPatentAssignee:GILEADSCIENCESINC;NURIXTHERAPEUTICSINC-WO2021/226262,2021,A1Locationinpatent:Page/Pagecolumn74
[1]CurrentPatentAssignee:GILEADSCIENCESINC;NURIXTHERAPEUTICSINC-WO2021/226262,2021,A1
Title: Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.